{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:28:18Z","timestamp":1783013298236,"version":"3.54.6"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:p>This study aimed to explore the prenatal indicators in the second trimester of pregnancy and their association with chromosome abnormities (CA) to guide decisions toward invasive diagnostic procedures. Pregnant women who underwent prenatal screening and underwent amniocentesis in the second trimester in our Hospital between June 2017 and February 2019 were included in this retrospective cohort study. The reason for amniocentesis in prenatal screening and diagnoses was extracted from the charts. Finally, 3449 pregnant women were included. Of them, 181 were with CA confirmed by amniocentesis (i.e., the CA group), while 3268 were without CA (i.e., the non-CA group). Compared with the women in the non-CA group, those in the CA group were more likely to be older (30 [27,32] vs 29 [26,31], <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001), had higher gestational weeks (20 [19,23] vs 19 [18,23], <jats:italic toggle=\"yes\">P<\/jats:italic> = .008), an increased risk of advanced maternal age (AMA) (9.4% vs 2.2%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001), had an increased risk of NIPT (IRN) (5.1% vs 1.9%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001), had higher rates of a parental chromosome abnormality (PCA) (1.8% vs 0.9%, <jats:italic toggle=\"yes\">P<\/jats:italic> = .002), and had increased risk of trisomy 21 (IRT21) (63.0% vs 45.3%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001). AMA (OR = 4.22, 95% CI: 2.35\u20137.58, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001; AUC = 0.536), IRN (OR = 10.62, 95% CI: 6.66\u201316.94, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001; AUC = 0.589), PCA (OR = 4.77, 95% CI: 2.01\u201311.32, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001; AUC = 0.584), and IRT21 (OR = 0.67, 95% CI: 0.47\u20130.89, <jats:italic toggle=\"yes\">P<\/jats:italic> = .008; AUC = 0.515) were independently associated with CA. AMA, IRN, IRT21, and PCA during the second trimester were independently associated with CA, but their predictive values for CA were relatively low. Combining those indicators may improve the predictive value.<\/jats:p>","DOI":"10.1097\/md.0000000000034762","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T21:01:02Z","timestamp":1693602062000},"page":"e34762","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association between chromosome abnormities and prenatal diagnosis indicators screening in the second trimester of pregnancy"],"prefix":"10.1097","volume":"102","author":[{"given":"Ci","family":"Pan","sequence":"first","affiliation":[{"name":"Prenatal Diagnosis Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Li","sequence":"additional","affiliation":[{"name":"Jinan Pediatric Research Institute, Qilu Children\u2019s Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guomei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fufang","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/MOP.0000000000000145","article-title":"Advances in genetic prenatal diagnosis and screening.","volume":"26","author":"Hardisty","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s10815-020-01825-3","article-title":"Comparison of indications and results of prenatal invasive diagnostic tests before and after the implementation of the use of cell-free fetal DNA: a tertiary referral center experience.","volume":"37","author":"Okmen","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"R3-20250504","first-page":"CD012599","article-title":"First and second trimester serum tests with and without first trimester ultrasound tests for Down\u2019s syndrome screening.","volume":"3","author":"Alldred","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-med-072115-033220","article-title":"Noninvasive prenatal DNA testing: the vanguard of genomic medicine.","volume":"68","author":"Hui","year":"2017","journal-title":"Annu Rev Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/gim.2017.56","article-title":"Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases.","volume":"19","author":"Ehrich","year":"2017","journal-title":"Genet Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.tjog.2017.10.004","article-title":"Prenatal diagnosis of Down syndrome: a 13-year retrospective study.","volume":"56","author":"Vi\u010di\u0107","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R7-20250504","first-page":"33","article-title":"Analysis of different prenatal screening programs and strategies for Down\u2032s syndrome.","volume":"23","author":"Zhao","year":"2015","journal-title":"Chin J Birth Health Hered"},{"key":"R8-20250504","first-page":"723","article-title":"Compliance and efficacy of standard antenatal care model.","volume":"27","author":"Sun","year":"2005","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrg.2016.97","article-title":"Prenatal and pre-implantation genetic diagnosis.","volume":"17","author":"Vermeesch","year":"2016","journal-title":"Nat Rev Genet"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/humupd\/dmn037","article-title":"A review of decision support technologies for amniocentesis.","volume":"14","author":"Durand","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/uog.19107","article-title":"Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.","volume":"53","author":"Lostchuck","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jog.12144","article-title":"Clinical and cytogenetic results of a large series of amniocentesis cases from Turkey: report of 6124 cases.","volume":"40","author":"Ocak","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"R13-20250504","first-page":"644","article-title":"Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester.","volume":"46","author":"Zhang","year":"2011","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/01443615.2015.1041889","article-title":"Karyotype analysis with amniotic fluid in 12365 pregnant women with indications for genetic amniocentesis and strategies of prenatal diagnosis.","volume":"36","author":"Xiao","year":"2016","journal-title":"J Obstet Gynaecol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ejhg.2015.116","article-title":"Attitudes of women of advanced maternal age undergoing invasive prenatal diagnosis and the impact of genetic counselling.","volume":"24","author":"Godino","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"R16-20250504","first-page":"737","article-title":"Second trimester maternal serum screening for Down\u2019s syndrome in women of advanced maternal age: a multicenter prospective study.","volume":"43","author":"Qi","year":"2008","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"R17-20250504","first-page":"1","article-title":"Quality control and hot issues of maternal serum prenatal screening in China.","volume":"36","author":"Lv","year":"2013","journal-title":"Chin J Lab Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/jmf.13.2.80.84","article-title":"Cost analysis of Down syndrome screening in advanced maternal age.","volume":"13","author":"Hartnett","year":"2003","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.7863\/jum.2003.22.11.1191","article-title":"Genetic sonography: an option for women of advanced maternal age with negative triple-marker maternal serum screening results.","volume":"22","author":"DeVore","year":"2003","journal-title":"J Ultrasound Med"},{"key":"R20-20250504","first-page":"1","article-title":"Perspectives of pregnant people and clinicians on noninvasive prenatal testing: a systematic review and qualitative meta-synthesis.","volume":"19","author":"Vanstone","year":"2019","journal-title":"Ont Health Technol Assess Ser"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000491750","article-title":"Clinical and economic impact of adopting noninvasive prenatal testing as a primary screening method for fetal aneuploidies in the general pregnancy population.","volume":"45","author":"Kostenko","year":"2019","journal-title":"Fetal Diagn Ther"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000001051","article-title":"Committee opinion no. 640: cell-free DNA screening for fetal aneuploidy.","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R23-20250504","first-page":"578","article-title":"DNA sequencing versus standard prenatal aneuploidy screening.","volume":"371","author":"Bianchi","year":"2014","journal-title":"N Engl J Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12041-021-01304-3","article-title":"Parental balanced chromosomal rearrangement leading to major genomic imbalance and an autosomal trisomy resulting in consecutive pregnancy loss: a case report.","volume":"100","author":"Shrivastava","year":"2021","journal-title":"J Genet"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.semperi.2018.12.002","article-title":"Genetic abnormalities and pregnancy loss.","volume":"43","author":"Blue","year":"2019","journal-title":"Semin Perinatol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/bmj.38735.459144.2F","article-title":"Reproductive outcome after chromosome analysis in couples with two or more miscarriages: case-control study.","volume":"332","author":"Franssen","year":"2006","journal-title":"Br Med J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:12:00Z","timestamp":1746324720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":26,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034762","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}